|
ÁÖÁ¦1 |
Characterization of the cellular effects of myeloperoxidase-derived oxidants on h9c2 cardiac myoblasts. |
ÁÖÁ¦2 |
Work-in Progress |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
MIRACLE ¼¼¹Ì³ª |
°³ÃֱⰣ |
2019.04.12 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
|
|
|
ÁÖÁ¦1 |
Diabetic Cardiomyopath |
ÁÖÁ¦2 |
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
MIRACLE ¼¼¹Ì³ª |
°³ÃֱⰣ |
2019.04.05 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
1 |
÷ºÎÆÄÀÏ |
|
|
|
ÁÖÁ¦1 |
CRBN is a negative regulator of mitochondrial function in multiple myeloma |
ÁÖÁ¦2 |
Characterization of atrial histopathological and electrophysiological changes in a mouse model of aging |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
MIRACLE ¼¼¹Ì³ª |
°³ÃֱⰣ |
2019.03.29 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
|
|
|
ÁÖÁ¦1 |
A lipase-independent pathway of lipid release and immune modulation by adipocytes |
ÁÖÁ¦2 |
|
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
MIRACLE ¼¼¹Ì³ª |
°³ÃֱⰣ |
2019.03.15 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
1 |
÷ºÎÆÄÀÏ |
|
|
|
ÁÖÁ¦1 |
The cereblon facilitates CaV1.2¥á subunit ubiquitination and proteasomal degradation to regulate cardiac contractility |
ÁÖÁ¦2 |
Cardiac specific PRMT1 ablation causes heart failure through CaMKII dysregulation |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
MIRACLE ¼¼¹Ì³ª |
°³ÃֱⰣ |
2019.03.08 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
|
|
|
ÁÖÁ¦1 |
Cereblon attenuates DNA damage-induced apoptosis by regulating the transcription-independent function of p53 |
ÁÖÁ¦2 |
|
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
MIRACLE ¼¼¹Ì³ª |
°³ÃֱⰣ |
2019.02.22 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
1 |
÷ºÎÆÄÀÏ |
|
|
|
ÁÖÁ¦1 |
Human Embryonic Stem Cell Culture Protocol |
ÁÖÁ¦2 |
A novel cereblon modulator for targeted protein degradation |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
MIRACLE ¼¼¹Ì³ª |
°³ÃֱⰣ |
2019.02.08 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
|
|
|
ÁÖÁ¦1 |
Transient Receptor Potential Ankyrin 1 Activation within the Cardiac Myocyte Limits Ischemia–reperfusion Injury in Rodents |
ÁÖÁ¦2 |
|
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
MIRACLE ¼¼¹Ì³ª |
°³ÃֱⰣ |
2019.02.01 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
1 |
÷ºÎÆÄÀÏ |
|
|
|
ÁÖÁ¦1 |
TRPA1 modulation by CRBN and its effect on mitochondrial function |
ÁÖÁ¦2 |
|
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
MIRACLE ¼¼¹Ì³ª |
°³ÃֱⰣ |
2019.01.25 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
1 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2019.01.25_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
ÁÖÁ¦1 |
Mutation of KCNQ2 and epileptic encephalopathy |
ÁÖÁ¦2 |
Cardiac branched-chain amino acid oxidation is reduced during insulin resistance in the heart |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
MIRACLE ¼¼¹Ì³ª |
°³ÃֱⰣ |
2019.01.18 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2019.01.18_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
|
1 2 3 4 5 6 7 8 9 10 |